OLGA MEDINA: Open Payments
NPI 1982950440 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 20 payments from 10 companies in 2025. Trend: 2023 $450 · 2024 $895 · 2025 $1,314
Food & beverage: $1,263Education: $51
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 5 | $302 |
| Madrigal Pharmaceuticals | 3 | $293 |
| Gilead Sciences, Inc. | 3 | $210 |
| Phathom Pharmaceuticals, Inc. | 1 | $139 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 2 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $74 |
| GENZYME CORPORATION | 1 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: ZENPEP, REZDIFFRA, VOQUEZNA, Livdelzi, GIVLAARI, TREMFYA, XIFAXAN, DUPIXENT.
Industry payments across FL — which companies pay providers there.
